
Wuhan Aoke Botai Biotechnology Co., Ltd., formerly known as Wuhan Aoke Biotechnology Co., Ltd., was established in 2002. It is a high-tech company specializing in the research and development, production, and sales of in vitro diagnostic raw materials (including antigens and antibodies), as well as providing customized services for various monoclonal antibodies, multi antibodies, and recombinant proteins. After decades of development, the company has passed ISO13485 and ISO9001 quality system certifications, and has been awarded honors such as Optics Valley Gazelle, 3551 Talent, Provincial Innovative Small and Medium Enterprises, and Provincial "Specialized, Refined, and New" Small and Medium Enterprises. After years of dedicated research and development, the company has created two widely acclaimed technology platforms in the industry, namely the mouse monoclonal antibody hybridoma platform and the recombinant protein expression platform. The mouse hybridoma platform is a leader in... [
View More..]